Olfactory receptor neuron dysfunction in schizophrenia

Neuropsychopharmacology

Volumn 34, Issue 3, 2009, Pages 767-774

  Turetsky, Bruce I ^a   Hahn, Chang Gyu ^a   Arnold, Steven E ^a   Moberg, Paul J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Electroolfactogram; Olfaction; Olfactory epithelium; Olfactory receptor neuron; Schizophrenia; Signal transduction

Indexed keywords

CYCLIC AMP; HYDROGEN SULFIDE;

ADULT; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; IN VIVO STUDY; MALE; NOSE MUCOSA; OLFACTOMETRY; OLFACTORY RECEPTOR; OLFACTORY SYSTEM; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SMELLING;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; HYDROGEN SULFIDE; MALE; MIDDLE AGED; NASAL MUCOSA; OLFACTION DISORDERS; OLFACTORY RECEPTOR NEURONS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 58149458856     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2008.139     Document Type: Article

References (40)

1. Andreasen NC (1983). The Scale for the Assessment of Negative Symptoms (SANS). The University of Iowa: Iowa City, IA.
2. Andreasen NC (1984). The Scale for the Assessment of Positive Symptoms (SAPS). The University of Iowa: Iowa City, IA.
3. Arnold SE, Han LY, Moberg PJ, Turetsky BI, Gur RE, Trojanowski JQ et al (2001). Dysregulation of olfactory receptor neuron lineage in schizophrenia. Arch Gen Psychiatry 58: 829-835.
4. Brewer WJ, Wood SJ, McGorry PD, Francey SM, Phillips LJ, Yung AR et al (2003). Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am J Psychiatry 160: 1790-1794.
5. Chetkovich DM, Sweatt JD (1993). NMDA receptor activation increases cyclic AMP in area CA1 of the hippocampus via calcium/calmodulin stimulation of adenylyl cyclase. J Neurochem 61: 1933-1942.
6. Dluzen DE, Kreutzberg JD (1996). Norepinephrine is lateralized within the olfactory bulbs of male mice. J Neurochem 66: 1222-1226.
7. Doty RL, Bromley SM, Moberg PJ, Hummel T (1997). Laterality in human nasal chemoreception. In: Christman S (ed). Cerebral Asymmetries in Sensory and Perceptual Processing. North-Holland: Amsterdam. pp 497-542.
8. Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L (1984). Smell identification ability: changes with age. Science 226: 1441-1443.
9. Féron F, Perry C, Hirning MH, McGrath J, Mackay-Sim A (1999). Altered adhesion, proliferation and death in neural cultures from adults with schizophrenia. Schizophr Res 40: 211-218.
10. Gesteland RC, Yancey RA, Farbman AI (1982). Development of olfactory receptor neuron selectivity in the rat fetus. Neuroscience 7: 3127-3136.
11. Hahn CG, Gomez G, Restrepo D, Friedman E, Josiassen R, Pribitkin EA et al (2005). Aberrant intracellular calcium signaling in olfactory neurons from patients with bipolar disorder. Am J Psychiatry 162: 616-618.
12. +-induced calcium responses in mouse olfactory receptor neurons in situ. J Neurophysiol 91: 1492-1499.
13. Heine O, Galaburda AM (1986). Olfactory asymmetry in the rat brain. Exp Neurol 91: 392-398.
14. Lowe G, Nakamura T, Gold GH (1989). Adenylate cyclase mediates olfactory transduction for a wide variety of odorants. Proc Natl Acad Sci USA 86: 5641-5645.
15. Maxwell ME (1992). Maxwell Family Interview for Genetic Studies (FIGS): A Manual for FIGS. Clinical Neurogenetics Branch Intramural Research Program, National Institute of Mental Health: Bethesda, MD.
16. McCurdy RD, Féron F, Perry C, Chant DC, McLean D, Matigian N et al (2006). Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses. Schizophr Res 82: 163-173.
17. Millar JK, Pickard BS, Mackie S, James R, Christie S, Buchanan SR et al (2005). DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310: 1187-1191.
18. Miller GA, Chapman JP (2001). Misunderstanding analysis of covariance. J Abnorm Psychol 110: 40-48.
19. Minoretti P, Politi P, Coen E, Di Vito C, Bertona M, Bianchi M et al (2006). The T393C polymorphism of the GNAS1 gene is associated with deficit schizophrenia in an Italian population sample. Neurosci Lett 397: 159-163.
20. Moberg PJ, Agrin R, Gur RE, Gur RC, Turetsky BI, Doty RL (1999). Olfactory dysfunction in schizophrenia: a qualitative and quantitative review. Neuropsychopharmacology 21: 325-340.
21. Moberg PJ, Doty RL, Turetsky BI, Arnold SE, Mahr RN, Gur RC et al (1997). Olfactory identification deficits in schizophrenia: correlation with duration of illness. Am J Psychiatry 154: 1016-1018.
22. Natsukari N, Kulaga H, Baker I, Wyatt RJ, Masserano JM (1997). Increased cyclic AMP response to forskolin in Epstein-Barr virus-transformed human B-lymphocytes derived from schizophrenics. Psychopharmacology (Berl) 130: 235-241.
23. Neves SR, Ram PT, Iyengar R (2002). G protein pathways. Science 296: 1636-1639.
24. Nurnberger Jr JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J et al (1994). Diagnostic Interview for Genetic Studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51: 849-859.
25. Overall JR, Gorham DR (1962). The Brief Psychiatric Rating Scale. Psychol Rep 10: 799-812.
26. Prasada Rao PD, Finger TE (1984). Asymmetry of the olfactory system in the brain of the winter flounder, Pseudopleuronectes americanus. J Comp Neurol 225: 492-510.
27. Rawson NE, Gomez G, Cowart B, Restrepo D (1998). The use of olfactory receptor neurons (ORNs) from biopsies to study changes in aging and neurodegenerative diseases. Ann N Y Acad Sci 855: 701-707.
28. Rodriguez-Gomez FJ, Rendon-Unceta MC, Sarasquete C, Munoz-Cueto JA (2000). Localization of tyrosine hydroxylase-immunoreactivity in the brain of the Senegalese sole, Solea senagalensis. J Chem Neuroanat 19: 17-32.
29. Ronnett GV, Moon C (2002). G proteins and olfactory signal transduction. Annu Rev Physiol 64: 189-222.
30. Sklar PB, Anholt RR, Snyder SH (1986). The odorant-sensitive adenylate cyclase of olfactory receptor cells. Differential stimulation by distinct classes of odorants. J Biol Chem 261: 15538-15543.
31. Snitz BE, MacDonald III A, Cohen JD, Cho RY, Becker T, Carter CS (2005). Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. Am J Psychiatry 162: 2322-2329.
32. Sweet RA, Bergen SE, Sun Z, Marcsisin MJ, Sampson AR, Lewis DA (2007). Anatomical evidence of impaired feedforward auditory processing in schizophrenia. Biol Psychiatry 61: 854-864.
33. Takeuchi H, Imanaka Y, Hirono J, Kurahashi T (2003). Cross-adaptation between olfactory responses induced by two subgroups of odorant molecules. J Gen Physiol 122: 255-264.
34. Turetsky BI, Kohler CG, Gur RE, Moberg PJ (2008). Olfactory physiological impairment in first-degree relatives of schizophrenia patients. Schizophr Res 102: 220-229.
35. Turetsky BI, Moberg PJ, Arnold SE, Doty RL, Gur RE (2003a). Low olfactory bulb volume in first-degree relatives of patients with schizophrenia. Am J Psychiatry 160: 703-708.
36. Schizophr Res 102: 220-9.
37. Turetsky BI, Moberg PJ, Owzar K, Johnson SC, Doty RL, Gur RE (2003b). Physiologic impairment of olfactory stimulus processing in schizophrenia. Biol Psychiatry 53: 403-411.
38. Turetsky BI, Moberg PJ, Roalf DR, Arnold SE, Gur RE (2003c). Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia. Arch Gen Psychiatry 60: 1193-1200.
39. Turetsky BI, Moberg PJ, Yousem DM, Doty RL, Arnold SE, Gur RE (2000). Reduced olfactory bulb volume in patients with schizophrenia. Am J Psychiatry 157: 828-830.
40. Weiss AP, Goff D, Schacter DL, Ditman T, Freudenreich O, Henderson D et al (2006). Fronto-hippocampal function during temporal context monitoring in schizophrenia. Biol Psychiatry 60: 1268-1277.